Brant Binder is listed as an executive officer and director on 7 SEC Form D filings by 4 issuers between Nov 2011 and Jul 2023: Ernexa Therapeutics Inc. (Cambridge, MA — biotechnology — 2023; $12M reported sold to 20 investors), ZebiAI Therapeutics, Inc. (Chestnut Hill, MA — other technology — 2020; $10M reported sold to 6 investors), Psy Therapeutics, Inc. (Boston, MA — pharmaceuticals — 2019; $6.76M reported sold to 23 investors) and X BODY INC (Waltham, MA — biotechnology — 2011–2015; $4.14M reported sold to 2 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $32.9M sold in total.
Listed alongside Richard W. Wagner (6 shared filings), Gordon Binder (3 shared filings), Gregory Fiore (2 shared filings), Matthew Angel (2 shared filings), Sandra Gurrola (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Brant. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for Brant Binder and found 7 differences, 2 worth asking the sponsor about: Investor count went down between filings; Form D filed 785 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.